Why is DarioHealth Corp. ?
1
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -18.73%, its profits have risen by 31.6%
2
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 12.33% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -18.73% returns
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is DarioHealth Corp. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
DarioHealth Corp.
-19.66%
0.40
2031.31%
S&P 500
13.22%
0.61
20.17%
Quality key factors
Factor
Value
Sales Growth (5y)
30.69%
EBIT Growth (5y)
-62.86%
EBIT to Interest (avg)
-47.13
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
0.25
Tax Ratio
0.37%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
27.57%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.42
EV to EBIT
-0.67
EV to EBITDA
-0.80
EV to Capital Employed
0.44
EV to Sales
1.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-65.26%
ROE (Latest)
-48.75%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Movement
8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -26.79 MM
RAW MATERIAL COST(Y)
Fallen by -25.89% (YoY
NET PROFIT(Q)
Highest at USD -3.63 MM
-7What is not working for the Company
INTEREST(HY)
At USD 0.07 MM has Grown at 44.44%
DEBT-EQUITY RATIO
(HY)
Highest at 14.77 %
NET SALES(Q)
Lowest at USD 5.37 MM
Here's what is working for DarioHealth Corp.
Operating Cash Flow
Highest at USD -26.79 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Highest at USD -3.63 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Net Profit
At USD -3.63 MM has Grown at 59.63%
over average net sales of the previous four periods of USD -8.98 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Raw Material Cost
Fallen by -25.89% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for DarioHealth Corp.
Net Sales
At USD 5.37 MM has Fallen at -23.39%
over average net sales of the previous four periods of USD 7.01 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Interest
At USD 0.07 MM has Grown at 44.44%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Net Sales
Lowest at USD 5.37 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Debt-Equity Ratio
Highest at 14.77 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






